{{roughtranslation|time=2018-07-16T01:35:38+00:00}}
{{Drugbox
| verifiedrevid = 461093245
| IUPAC_name =1-(2-ethoxyethyl)-2-(4-methyl-1,4-diazepan-1-yl)-benzimidazole
| image = Emedastine structure.svg
<!--Clinical data-->
| tradename = Emadine
| Drugs.com = {{drugs.com|monograph|emadine}}
| pregnancy_category =  
| licence_EU = yes
| legal_status = Rx-only
| routes_of_administration = 局部外用 (眼藥水)
<!--Pharmacokinetic data-->
| bioavailability = ~50% (口服) ({{tsl|en|Cmax (pharmacology)|最大血漿濃度所需時間|T<sub>max</sub>}} = 1–2 小時)<ref name = "PI">{{cite web|title=Emadine (emedastine difumarate ophthalmic solution) 0.05%. Full Prescribing Information|url=http://ecatalog.alcon.com/PI/Emadine_us_en.pdf|publisher=Alcon Laboratories, Inc. 6201 South Freeway Fort Worth, Texas 76134, USA|accessdate=5 January 2016}}</ref>
| protein_bound =  
| metabolism = [[肝臟|肝臟]]
| elimination_half-life = 3–4 小時 (口服)； 10 小時 (局部外用)
<!--Identifiers-->
| IUPHAR_ligand = 7174
| CAS_number_Ref = {{cascite|correct|??}}
| CAS_number = 87233-61-2
| ATC_prefix = S01
| ATC_suffix = GX06
| PubChem = 3219
| DrugBank_Ref = {{drugbankcite|correct|drugbank}}
| DrugBank = DB01084
| ChemSpiderID_Ref = {{chemspidercite|correct|chemspider}}
| ChemSpiderID = 3106
| UNII_Ref = {{fdacite|correct|FDA}}
| UNII = 9J1H7Y9OJV
| KEGG_Ref = {{keggcite|correct|kegg}}
| KEGG = D07890
| ChEBI_Ref = {{ebicite|correct|EBI}}
| ChEBI = 4779
| ChEMBL_Ref = {{ebicite|correct|EBI}}
| ChEMBL = 594
<!--Chemical data-->
| C=17 | H=26 | N=4 | O=1
| molecular_weight = 302.415 g/mol
| SMILES = O(CC)CCn1c(nc2ccccc12)N3CCCN(C)CC3
| StdInChI_Ref = {{stdinchicite|correct|chemspider}}
| StdInChI = 1S/C17H26N4O/c1-3-22-14-13-21-16-8-5-4-7-15(16)18-17(21)20-10-6-9-19(2)11-12-20/h4-5,7-8H,3,6,9-14H2,1-2H3
| StdInChIKey_Ref = {{stdinchicite|correct|chemspider}}
| StdInChIKey = KBUZBQVCBVDWKX-UHFFFAOYSA-N
}}

{{medical}}
'''依美斯汀'''（'''Emedastine'''，商品名稱： '''Emadine'''）是第二代抗組織胺，被用作[[眼藥水|眼藥水]]以減緩[[变应性结膜炎|過敏性結膜炎]]的症狀。依美斯汀屬於[[抗組織胺藥|H<sub>1</sub> 接收器抑制劑]]。依美斯汀藉由抑制[[組織胺|組織胺]]的作用來減緩過敏性結膜炎的症狀。當依美斯汀被應用在眼藥水用途時，會以di-[[延胡索酸|延胡索酸]]（difumarate）的形式存在。<ref>{{Cite journal 
| doi = 10.2165/00003495-200565020-00004 
| last1 = Bielory | first1 = L. 
| last2 = Lien | first2 = K. W. 
| last3 = Bigelsen | first3 = S. 
| title = Efficacy and tolerability of newer antihistamines in the treatment of allergic conjunctivitis 
| journal = Drugs 
| volume = 65 
| issue = 2 
| pages = 215–228 
| year = 2005 
| pmid = 15631542
}}</ref> 
[[FILE:Emedastine.jpg|thumb]]

==文獻來源==
{{reflist}}


{{Antihistamines}}
{{Histaminergics}}


[[Category:H1受体拮抗剂|Category:H1受体拮抗剂]]
[[Category:苯并咪唑|Category:苯并咪唑]]
[[Category:醚|Category:醚]]
[[Category:Diazepanes|Category:Diazepanes]]

{{respiratory-system-drug-stub}}